Drug Pipeline

PEEL-224 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06709495 Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With… Sarcoma Recruiting
NCT06721689 PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors Refractory Solid Tumors Recruiting
Phase 1
NCT05329103 A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors Advanced Solid Tumor Recruiting
Sponsors Running PEEL-224 Trials
Peel Therapeutics Inc (1) David S Shulman, MD (1) Theodore Laetsch (1)
Disease Areas
Sarcoma (2)
Get alerts when PEEL-224 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free